Intellia Therapeutics Inc buy Truist Financial Co.
Start price
04.03.25
/
50%
€8.43
Target price
04.03.26
€47.44
Performance (%)
-5.38%
Price
23.12.25
€7.98
Summary
This prediction is currently active. With a performance of -5.38%, the BUY prediction for Intellia Therapeutics Inc by Truist_Financial_Co_ is down slightly. This prediction currently runs until 04.03.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | 5.362% | 5.362% |
| iShares Core DAX® | 0.650% | 3.212% |
| iShares Nasdaq 100 | 1.650% | 0.322% |
| iShares Nikkei 225® | 1.232% | 1.549% |
| iShares S&P 500 | 1.413% | 0.282% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Truist Financial Co. from $90.00 to $50.00. They now have a "buy" rating on the stock.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€8.65
10.11.25
10.11.25
€12.11
10.11.26
10.11.26
-7.73%
23.12.25
23.12.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€23.43
24.06.24
24.06.24
€111.85
24.06.25
24.06.25
-64.98%
25.06.25
25.06.25